S. Itabashi et al., ABSENCE OF ASSOCIATION OF ALPHA(1)-ANTICHYMOTRYPSIN POLYMORPHISMS WITH ALZHEIMERS-DISEASE - A REPORT ON AUTOPSY-CONFIRMED CASES, Experimental neurology, 151(2), 1998, pp. 237-240
alpha 1-Antichymotrypsin (ACT) polymorphisms were examined in 79 cases
with autopsy-confirmed Alzheimer's disease (AD) as well as in 28 case
s with autopsy-confirmed nonneurological diseases to test the hypothes
is that ACT polymorphisms confer a risk to an individual to develop AD
. Neither ACT genotype frequency nor ACT allele frequency in the AD gr
oup was significantly different from the control group. The ACT polymo
rphic pattern was essentially the same among apolipoprotein E (apoE) e
psilon 4 carriers and noncarriers. The age at onset of AD was not sign
ificantly affected by the inherited dose of ACT/A allele. Taking toget
her, our observations do not confirm the effect of the ACT/A allele as
a risk. factor for developing AD in addition to the ApoE epsilon 4 al
lele. (C) 1998 Academic Press.